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ABSTRACT
Background: Respiratory syncytial virus (RSV) infection causes asthma-like symptoms in infants and young
children. Although an increase in several mediators in the airway during RSV infection has been reported, the
mechanisms involved in airway inflammation are not fully understood. The aim of this study was to investigate
the immunological deviation associated with airway inflammation by measuring cytokine and chemokine levels
in the airway during RSV infection.
Methods: One hundred and ten children under 3 years of age with respiratory symptoms were enrolled in this
study from November 2004 through January 2005. Nasopharyngeal secretions (NPAs) were gently aspirated
and analyzed with RSV antigen, thereafter the concentrations of IL-4, IL-10, IFN-γ, and RANTES were meas-
ured using an ELISA kit. We also investigated the prognosis of each child after 1 year by reference to clinical
records or by interviews and re-evaluated the cytokine and chemokine levels.
Results: Of the subjects, 70 children were RSV positive and 40 were negative. Only 4 children were given a
diagnosis of asthma by the pediatrician when NPAs were collected. The levels of IL-4, IL-10, and RANTES
were significantly higher in the RSV-positive patients than RSV-negative patients with P values at 0.0362,
0.0007, and 0.0047, respectively. In contrast, there was no significant difference in the levels of IFN-γ. Further-
more, there was a significant positive correlation between IL-10 and RANTES.
Conclusions: The increased production of IL-4, IL-10, and RANTES in the airway may play an important role
in the pathophysiological mechanisms of RSV infection.
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INTRODUCTION
Respiratory syncytial virus (RSV) is a non-segmented,
single-stranded RNA virus belonging to the
Paramixoviridae family. Most young children within
their first few years of life are susceptible to infection
with this toxic virus.1 RSV infection produces respira-
tory symptoms and 30% of patients develop lower res-
piratory tract illness, including bronchiolitis, or respi-
ratory failure.2 In Japan, RSV infection was diagnosed
in 31.4% of hospitalized patients under 3 years of age
with lower respiratory infection.3 The development of
asthma following RSV infection remains unclear from
previous clinical studies.4 Sigurs et al. reported in
their elegant study that infants with severe RSV infec-
tion developed a higher risk of sensitization to aller-
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gens and allergic asthma.5,6 In contrast, Stein et al. re-
ported that RSV infection in the first year of life was a
risk factor for the development of recurrent wheeze
before 11 years of age, however this association did
not persist to 13 years of age.7 Taussig et al. reported
3 phenotypes of wheeze in early childhood through
adolescence in the Tucson Children’s Respiratory
Study.8 Some patients with RSV infection-induced
wheeze under 3 years of age subsequently developed
non-atopic recurrent wheeze. Although they suffered
recurrent wheeze until 7 years of age, they finally out-
grew the condition and exhibited no more signs of
bronchial hyperresponsiveness. Therefore the condi-
tion of these patients was not considered to be associ-
ated with atopic asthma. These observations indi-
cated that not only RSV infection, but also differences
in the self-immune response to RSV, might contribute
to the asthma-like symptoms in children.
Recently, the level of several inflammatory cytoki-
nes in the airway, including interleukin (IL)-2,9 IL-4,10
IL-5,11 IL-6,12 IL-9,13 IL-10,10 IL-12,10 IL-18,10,14 tumor
necrotic factor (TNF)-α,15 and interferon (IFN)-γ10,16
have been reported to be associated with RSV infec-
tion. However, the mechanisms that are involved in
airway inflammation in response to viral-induced
bronchiolitis are not fully understood. Based on the
current understanding of allergic diseases including
asthma, these conditions are considered to arise from
an irregular balance among T-cell phenotypes. This
entails not only a shift in the T-helper 1T-helper 2
(Th1Th2) balance, but also includes the action of
the regulatory T cells that play an important role in
the pathophysiological response against various stim-
uli such as respiratory viruses and airborne allergens.
Indeed IL-10, which is produced by regulatory T
cells, is characterized by the abolition of allergen-
induced specific T-cell proliferation and the suppres-
sion of Th1-type cytokine (IFN-γ) or Th2-type cy-
tokine (IL-4) production.17 Hence, we investigated
the cytokine profile in the airways of young children
with RSV infection measuring the cytokine level in
nasopharyngeal aspirates (NPAs). Moreover, we
measured chemokine [regulated on activation normal
T-cell expressed and secreted (RANTES)] produc-
tion, which may be associated with the attraction of
inflammatory cells such as Th2-type lymphocytes or
eosinophils.
METHODS
STUDY DESIGN
One hundred and ten children under 3 years of age
were enrolled in this study from November 2004
through January 2005 at the Daido Hospital in Aichi.
The inclusion criteria were those individuals who had
at least one respiratory symptom, such as cough,
wheeze, running nose, sneeze, or snore, and who
were suspected by professional pediatricians to be in-
fected with RSV. We excluded children who had car-
diac disease, immunodeficiency, chronic inflamma-
tory disease, congenital respiratory disorder, chronic
lung disease after infantile respiratory distress syn-
drome, and immature infants of less than 2,500 g
weight at birth. No children were treated with antibi-
otics or steroid when NPAs were collected. Four chil-
dren were given a diagnosis of asthma by the pedia-
trician and 18 children had atopic status when NPAs
were collected. After obtaining written informed con-
sent from the parents, within a few days with symp-
toms NPAs were gently aspirated by well-trained
nurses, using a sterilized suction catheter of 10 Fr di-
ameter connected to a graduated trap-tube. After the
collection of 1 ml NPA samples, 2 ml of sterilized sa-
line was immediately added, and the resulting sus-
pension was well mixed at the hospital laboratory.
These samples were analyzed by using a Directigen
EZ RSVTM Test kit (BD, NJ, USA) to detect the RSV
antigen. The samples were centrifuged at 3000 rpm
for 15 minutes at 4℃, and thereafter the supernatants
were collected and stored at −80℃ until assay. We ex-
cluded any samples with visual blood contamination.
We analyzed the concentrations of IL-4, IL-10, IFN-γ,
and RANTES using an ELISA kit (R&D systems,
Minneapolis, MN, USA) following the protocol rec-
ommended by the manufacturer.
A physical examination of each patient was under-
taken by pediatricians before the NPA collection. Us-
ing auscultation, we confirmed the presence of
wheeze in those who had apparent wheeze on expira-
tion. The diagnosis of asthma was defined as having a
history of wheeze of more than three times. Atopy
was defined as a positive level of more than one spe-
cific IgE antibody against house dust mite, grass pol-
len, cow’s milk, or hen’s egg white.
We followed the prognosis of patients by reference
to patient records 1 year from the date on which the
initial diagnosis had been made. This study was ap-
proved by the Ethics Committee of Daido Hospital
and carried out at a single hospital setting for both in-
patients and outpatients.
STATISTICAL ANALYSIS
Statistical analysis was performed using the Mann-
Whitney U test and Spearman rank correlation to test
for similarities and differences between the RSV-
positive group [RSV (+)] and the RSV-negative group
[RSV (−)]. The association between RSV and atopy,
atopy and wheeze, atopy and developing asthma were
analyzed by using Fisher’s exact test. A P-value of
less than 0.05 was considered to indicate a statisti-
cally significant difference.
RESULTS
SUBJECTS
The backgrounds of RSV (+) patients (n = 70) and
RSV (−) patients (n = 40) are shown in Table 1. There
was no significant difference in the mean ages of RSV
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Fig. 1 IFN-γ and IL-4 levels in RSV ( ＋ ) and RSV ( － )
patients: (A) For IFN-γ, there was no significant diference 
between the groups (p＝0.6916). (B) IL-4 was increased to 
a greater extent in RSV ( ＋ )than in RSV ( － )patients 
(p＝0.0362) (Mann-Whitney U test).
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Table 1 Subject background and prognosis: Atopy/non-atopy was defined by a specific IgE antibody to common alergens. 
Transient wheeze was wheeze experienced less than 3 times post-infection over a period of 1 year. Asthma was diagnosed by 
a pediatrician.
RSV ( － )RSV ( ＋ )
40 (20)70 (33)n (female)
5 (13%)13 (18%)Atopy
1.11 ± 0.781.22 ± 0.86Average age
－＋－＋Wheezing
20 (4)20 (11)16 (7)54 (34)N (admission)
Prognosis
1/185/105/713/34Atopy/non-atopy
07 (47%)014 (30%)Transient wheeze
4 (21%)8 (50%)2 (17%) 7 (15%)Asthma
(+) and RSV (−) patients, (1.22 ± 0.86 years and 1.11 ±
0.78 years, respectively). Four children with RSV (+)
were given a diagnosis of asthma by a pediatrician.
Thirteen children (18%) in the RSV (+) group and 5
(13%) in the RSV (−) group were atopic when NPAs
were collected. There was no significant association
between RSV and atopy (p = 0.5004). Furthermore
there was no significant association between atopy
and wheeze when the NPAs were collected (p =
0.7636). The presence of wheeze was significantly
higher in RSV (+) children (n = 54, 77%) than in RSV
(−) children (n = 20, 50%). There was no patient in
this study who needed tracheal intubation or me-
chanical ventilation. Among the RSV (+) patients, 41
children (59%) were admitted, whereas among the
RSV (−) patients 15 children (38%) were admitted to
the hospital.
MEASURMENT OF CYTOKINES AND CHEMOKI-
NES
IFN-γ is the representative Th1-type cytokine which
suppresses the production of Th2-type cytokines and
enhances cellular immunity. Unexpectedly, we ob-
served no significant difference in the levels of IFN-γ
between the two groups (p = 0.6916) (Fig. 1A). IL-4,
which is one of the Th2-type cytokines, induces the
proliferation of Th2-type cells and suppresses the de-
velopment of Th1-type cells. Moreover IL-4 induces
IgE production and is strongly associated with aller-
gies. We excluded one patient because the IL-4 level
was below the detection limit. We found no back-
ground differences in this patient. Although the con-
centration range of IL-4 was very narrow, we ob-
served a small but significant increase in the level of
IL-4 in RSV (+) patients as compared with RSV (−) pa-
tients (p = 0.0362) (Fig. 1B).
IL-10 is one of the inhibitory cytokines produced
by regulatory T cells. IL-10 was shown to down-
regulate production of not only Th2-type cytokine
such as IL-4 but also Th1-type cytokine such as IFN-
γ.17,18 Although we excluded 38 patients, 21 in the
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Fig. 2 IL-10 and RANTES levels in RSV ( ＋ )and RSV ( － )
patients: (A) IL-10 and (B) RANTES were increased to a 
greater extent in RSV ( ＋ )than in RSV ( － )patients 
(p＝ 0.0007 and p＝ 0.0047, respectively; determined by 
the Mann-Whitney U test). 
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Fig. 3 Corelation between IL-10 and RANTES (1): In al 
subjects, IL-10 and RANTES were corelated (r＝ 0.2417, 
p＝0.0372; Spearman rank corelation).
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RSV (+) group and 17 in the RSV (−) group, because
their levels were below the limit of detection, we
found no differences in the backgrounds of these pa-
tients. The levels of IL-10 in the RSV (+) patients were
significantly higher than in the RSV (−) patients (p =
0.0007) (Fig. 2A).
RANTES is one of the inflammatory chemokines
which is thought to be secreted by airway epithelial
cells or by Th2-type cells. RANTES is a potential
chemoattractant for Th2-type cells and eosinophils. In
our study, the levels of RANTES were significantly in-
creased in the RSV (+) patients compared with the
RSV (−) patients (p = 0.0047) (Fig. 2B).
We compared cytokine levels between patients
with wheeze and without wheeze when NPAs were
collected. In the level of IL-4, IL-10 and RANTES
there was no difference between the groups (p =
0.5724, p = 0.7474, and p = 0.6672, respectively). We
also compared cytokine levels between atopic and
non-atopic patients. There was no difference between
the groups (IL-4; p = 0.9948, IL-10; p = 0.3743 and
RANTES; p = 0.0645, respectively).
CORRELATION BETWEEN IL-10 AND RANTES
Both IL-10 and RANTES were elevated in the NPAs
of RSV (+) children. We analyzed the relationship be-
tween IL-10 and RANTES. Expectedly, we found a
positive correlation between RANTES and IL-10 in all
patients. (r = 0.2417 p = 0.0372)(Fig. 3). Interestingly
the positive correlation between IL-10 and RANTES
was significant in the RSV (+) patients (r = 0.3662, p =
0.0097)(Fig. 4A), but not significant in the RSV (−) pa-
tients (p = 0.3579)(Fig. 4B).
RELATIONSHIP BETWEEN CYTOKINE AND
CHEMOKINE PROFILES, AND PROGNOSIS
After 1 year, 93 patients: 59 RSV (+) and 34 RSV (−),
were reevaluated by reference to hospital records or
by interview. The prognosis of each case was deter-
mined as follows: 1) patients who had wheeze less
than 2 times in the past year (transient wheeze), 2)
patients who had wheeze 2 times (recurrent wheeze)
or were given a diagnosis by a physician of asthma in
the past year, and 3) patients who did not have
wheeze. Fourteen RSV (+) patients with wheeze
(30%) and 7 RSV (−) patients with wheeze (47%) expe-
rienced transient wheeze (Table 1). In RSV (+) sub-
jects 15% of patients with wheeze and 17% without
wheeze were given a diagnosis of asthma. There was
no significant association between atopy and the de-
velopment of asthma (p = 0.4951). Among RSV (−)
subjects 50% of patients with wheeze were given a di-
agnosis of asthma. However, only 21% of patients
IL-10 and RANTES in RSV Infection
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Fig. 4 Corelation between IL-10 and RANTES (2): (A) In 
RSV ( ＋ )patients, there was a significant positive corela-
tion between IL-10 and RANTES (r＝0.3662, p＝0.0097). 
(B) In RSV ( － )patients, IL-10 was not significantly core-
lated with RANTES.
without wheeze were given a diagnosis of asthma. In
both the RSV (+) and RSV (−) groups, patients with-
out wheeze did not experience wheeze. We re-
evaluated the level of IL-4, IL-10, INF-γ, and RANTES
in NPAs with asthma or recurrent wheeze. There
were no significant differences between patients with
asthma and recurrent wheeze or without. Moreover
we found no significant correlation between atopic
status and RSV infection.
DISCUSSION
In this study we demonstrated the shift of pro-
inflammatory cytokine and chemokine production
with RSV infection, based on the following observa-
tions. Firstly, the levels of IL-4, IL-10, and RANTES in
the NPAs were all elevated in patients with RSV infec-
tion. Secondly, there was no significant difference be-
tween the RSV (+) and (−) patients with respect to the
levels of IFN-γ in the NPAs. Thirdly, IL-10 was signifi-
cantly correlated with RANTES in RSV (+) patients,
but not in RSV (−) patients.
Recurrent wheeze following RSV-induced bron-
chiolitis is thought to be one of the predisposing fac-
tors in the development of asthma. Approximately
30% of children with RSV infection develop bron-
chiolitis. The impact of RSV infection on the health-
related quality of life is critical.19 The mechanisms of
post-bronchiolitis wheezing induced by RSV infection
have been reported in many studies. Copenhaver et
al. reported that cord blood IFN-γ responses were in-
versely related to the frequency of viral respiratory in-
fections.20 Severe respiratory failure was observed in
RSV-infected infants with lower production of IFN-γ,
indicating that immunological clearance of the virus
could be affected in these patients.21 In contrast to
previous findings, we observed no difference in the
IFN-γ levels between RSV (+) and RSV (−) children
(Fig. 1A). Our patients had only mild to moderate res-
piratory problems, thus this discrepancy might be at-
tributable to the difference in clinical severity com-
pared with the previous studies.
On the other hand, we observed a small but signifi-
cant elevation of IL-4 in patients with RSV infection
(Fig. 1B). Kristjansson et al. reported that the level of
IL-4 was significantly higher in RSV-infected infants
of less than 3 months of age compared with those
above 3 months.22 Since we analyzed patients of all
ages together in this study, it may explain the ob-
served small difference in the IL-4 levels. IL-4 is an
important Th2 cytokine and is associated with airway
hyperresponsiveness.23 The increased production of
IL-4 can affect local responses to allergens.24 As a
consequence, asthma-like symptoms can be en-
hanced by a shift in the immune system from Th1 to
Th2. However, the elevation of IL-8 production in
blood rather than a skewing of the Th1Th2 cytokine
balance, such as the switch from IFN-γ to IL-4 produc-
tion from peripheral lymphocytes, was reported to be
a marker for severity in RSV infection.25 This might
be due to the difference in the local and systemic pro-
duction of cytokines in response to viral infections.26
Further investigations will be needed to clarify these
mechanisms.
We observed a significant increase in the IL-10 lev-
els in RSV (+) patients (Fig. 2A). IL-10 is thought to
be produced by Th2-type cells. However, recent in-
vestigations indicate that IL-10 is produced by T regu-
latory cells.27 IL-10 has been demonstrated to sup-
press the production and response of IFN-γ and IL-
4.28 Bont et al. reported that IL-10 produced by mono-
cytes in RSV-infected infants was implicated in post-
bronchiolitis wheeze.29 Other viruses in addition to
RSV, such as rhinovirus, also induced the expression
of the IL-10 gene in sputum from patients with acute
asthma attacks.30 In an animal asthma model, IL-10
has been reported to be the essential cytokine con-
tributing to airway hyperresponsivness.31,32 Taken to-
gether these observations indicate that IL-10 changes
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the immune response and thereby affects airway re-
activity. This finding is in contrast to a previous study
by Chung et al..33 They investigated only RSV bron-
chiolitis and reported that the levels of IL-10 were sig-
nificantly lower in patients with atopy than in those
without atopy. In our patients with subsequently diag-
nosed asthma or recurrent wheezing, we observed no
significant difference in the levels of IL-10 between
RSV (+) and RSV (−) individuals. Thus, multiple fac-
tors may be involved in the development of asthma or
recurrent wheeze post RSV infection.
The chemokine RANTES plays important roles in
the pathogenesis of asthma.34 In this study, RANTES
was significantly higher in RSV (+) children than in
RSV (−) children (Fig. 2B). Chung et al. reported that
RANTES and eosinophil cationic protein in the NPAs
of RSV-bronchiolitis patients were significantly higher
than in controls.35 They also indicated that RANTES
was significantly increased in infants who had experi-
enced subsequent wheezing. They concluded that
RANTES could have predictive value with respect to
the development of airway hyperactivity.34 In our
study we did not show any difference in RANTES lev-
els of patients with subsequent wheezing with RSV in-
fection. In vivo studies have demonstrated that differ-
ent kinetics were involved in the production of RAN-
TES post RSV infection, thus this may account for the
comparable RANTES levels observed in the present
study.
After 1 year, we re-evaluated the study subjects and
found that IL-4, IL-10 and RANTES levels were not
correlated to the atopic status or the development of
asthma. In early childhood, virus infection was ob-
served to be one of the risk factors for developing
asthma at 7 years of age.4 Thus, we will need to un-
dertake careful re-evaluation in the future.
We observed a significant positive correlation be-
tween IL-10 and RANTES in the RSV (+) patients, but
not in the RSV (−) patients. There was no correlation
between IL-10 and either IL-4 or IFN-γ, suggesting
that at an early phase of RSV infection IL-10 may not
affect Th1 or Th2 cell cytokine production. On the
other hand, IL-10 regulates IL-4 and IFN-γ within nor-
mal levels, but does not affect RANTES in the early
phase. Jafri et al. measured the cytokine levels after
inoculation of RSV in BALBc mice. They found time
differences in the production of each cytokine.36 We
measured cytokine levels not in the recovery phase
but in the acute phase. In contrast, Legg et al. re-
ported that the ratio of IL-4 to IFN-γ increased in
acute bronchiolitis to a greater extent than in RSV-
induced upper respiratory infection. They also indi-
cated that the ratio of IL-10 to IL-12 was significantly
higher in patients with acute bronchiolitis than in
those with upper respiratory infection.10 Recently,
Heaton et al. studied the in vitro T-cell response pat-
terns associated with different wheezing phenotypes
in children. They reported that bronchial hyperre-
sponsiveness in non-atopic patients was associated
with an elevation of antigen-specific and polyclonal IL-
10 production.37 Thereby the new findings of implica-
tion with IL-10 and RANTES in our study may play an
important role in the pathophysiological mechanisms
associated with RSV infection.
CONCLUSION
We conclude that IL-10 and RANTES increase in the
NPAs of patients with RSV infection and that they act
synergistically. Further study of the immunological
mechanism between Th1Th2-type cells and regula-
tory T cells will be needed to clarify the phenotype of
wheeze in RSV infection.
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